Sentences with phrase «because drug company»

Today's proposal to increase those fees by $ 1 billion may not sound ominous in itself, but it implies an impending, equivalent cut to federal funding, says Steven Grossman, deputy executive director at the Alliance for a Stronger FDA in Washington, D.C.. That's an unrealistic expectation, he adds, because drug companies have already gone through negotiations and reached an agreement with FDA on user fee increases.

That is because drug companies have to test them on dogs for their studies, and to fund a study for 7 or 10 years before releasing the product becomes very expensive for the drug companies.

In recent years, executions have become even more difficult to carry out because drug companies have protested the use of their products in lethal injections.

Not exact matches

Sysco says he suspected the technology would need to gain FDA approval from the time the company launched in 2005, because it was designing an app that physicians would prescribe like a drug or device.

They argue that many companies stick with traditional PBMs because drug pricing is so impossible to untangle that customers have no way to verify how much they're saving, if anything.

Matt de Silva, CEO of drug testing firm Notable Labs, said he co-founded the company after his father was diagnosed with multiple glioblastomas and was excluded from many trials because of the nature of his condition.

The overstatements came because the company essentially booked the sales of some drugs twice.

«And as long as that happens, your insurance company is not going to pay your bill if you take a drug and the pharmaceuticals are not going to develop the drugs because if nobody is going to pay for their use, why spend the money on that?»

The reason there's no generic Viagra yet is because Pfizer, the company that makes it, holds two patents for the drug: the first for Viagra's composition — which expired in 2012 — and the second for what's called a «method of treatment,» meaning how the drug is used.

That's because pharmaceutical companies go through the process of creating a treatment from beginning to end without any guarantee a drug will be effective and produce revenue.

Now, The Wall Street Journal reports that billionaire Carl Icahn has invested in the company, reportedly because he thinks the company's drug portfolio could be ripe for a takeover.

The Food and Drug Administration is deliberately preventing the public from getting natural cures for cancer and other diseases because of pressure from drug companDrug Administration is deliberately preventing the public from getting natural cures for cancer and other diseases because of pressure from drug compandrug companies.

«Criminals use U.S. shell companies to commit financial fraud, drug trafficking, even terrorist financing, in part because our states don't require anyone to name the owners of the companies they form,» Levin said in an email to Reuters.

The California Medical Association, which represents doctors in California, opposes the measure because of that claim, and also because the group said the cancellation of drug purchasing contracts the state already has with pharma companies «would remove many drugs from the Medi - Cal list of pre-approved medicines — creating a new prior authorization hurdle for patients and their physicians.»

Several drug companies, Merck, Pfizer and Amgen, released identically worded statements to CNBC on Monday they have «serious concerns about this poorly - written measure because of the negative impact it will have on Californians,» adding that, «We are part of a broad and growing coalition of organizations.»

Similarly, Mylan and other pharmaceutical companies can engage in price - gouging because they're the only ones producing these lifesaving drugs.

Bayer said in a statement that it doesn't control the cost for patients at the pharmacy, because copays are determined by insurers and pharmacy - benefit managers — an argument that pharmaceuticals companies have long made when facing criticism over drug prices.

It's hard to imagine anybody making a trip to Walgreens because the company spent $ 17 billion - plus to boost its stake in a drug wholesaler to 100 percent from 26 percent.

The reason why I think Merck is the safest way to invest in immunotherapy is because the company has a diverse portfolio of FDA approved drugs on the market.

Pharmaceutical companies can charge higher prices for drugs because they sell to so many buyers.

She added that Mylan had responded promptly when the Food and Drug Administration criticized the company's advertisement in 2012, and that the EpiPen had become more expensive because Mylan had invested in public awareness and improving the device.

The company also announced Q3 revenue that missed expectations, mostly because the 12 % growth of its psoriasis drug Otezla was considered disappointing.

Biotech companies that don't have new drugs or therapies in the pipeline yet (about 40 percent of all those that went public last year, in fact) tend to take advantage of an IPO window because they have serious cost burdens --- like multiple drug tests and regulatory approval --- that other VC - backed companies don't have.

One terminally ill patient in Oregon, requesting a chemotherapy drug that might extend her life, was refused because her insurance company wouldn't foot the bill.

Product quality is guaranteed because the company is regulated and in compliance with all requirements of the U.S. Department of Agriculture, the Canadian Food Inspection Service and the U.S. Food and Drug Administration.

Drug companies Pfizer and Medivation abandoned their Alzheimer's drug dimebon in January 2012, because the drug not only did not help patients in trials, but it made patients woDrug companies Pfizer and Medivation abandoned their Alzheimer's drug dimebon in January 2012, because the drug not only did not help patients in trials, but it made patients wodrug dimebon in January 2012, because the drug not only did not help patients in trials, but it made patients wodrug not only did not help patients in trials, but it made patients worse.

While the Food and Drug Administration (FDA) did not require approval of cryotherapy because it is a non-invasive procedure, the company believes that additional studies can help business with the added confirmation and explanation of benefits, as well as increase exposure of cryotherapy to the mainstream.

The FDA does not have specific trials on Cytotec for labor induction because the company that makes the drug did not apply for the approval.

These are classic signs of liver toxicity because these vitamins are made synthetically by drug companies.

In the U.S. some generic drugs have an inflated price because they are monopolized by one company.

The venture failed — partly because small, innovative companies couldn't afford years of testing to get a drug to market, for an uncertain pay - off at the end if the drug actually worked.

A 2013 joint report from epilepsy research organizations explained that «because the marketplace is already awash with [antiseizure drugs], many pharmaceutical companies now refrain from the expensive enterprise of developing new compounds.»

The company decided to set up the institute, he adds, because it expects to get «a large competitive advantage» if it can efficiently translate genetic information into drug targets.

Other companies, it said, have not submitted new research because they removed their drugs from the market altogether.

Developing broad - spectrum drugs for the battlefield has proved difficult because regulators are more accustomed to evaluating drugs that target one specific disease, and drug companies prefer to focus on diseases that affect many people rather than on obscure pathogens that could serve as bioweapons.

In an effort to strengthen her bones, Rubin gave her a growth factor called IGF - I — donated by a drug company because her insurance would not cover it — but the experiment had almost no measurable benefit.

That is a partial win for drug companies and patient groups, because the House version of the tax bill had eliminated the tax break entirely.

The affair once again underlines how fragile the vaccine market is, Sloan says: Because of high risks and low profits, many companies have given up making vaccines in favor of more lucrative drugs.

Because metformin is generic and cheap, drug companies have little profit motive to test it, according to Arnold.

The company that developed the drug, Tekmira Pharmaceuticals of Burnaby, Canada, and the Wellcome Trust, which sponsored the trial, announced today that they would not enroll any more patients because the trial had reached «a predefined statistical endpoint.»

Drug companies had long ago given up on targeting RAS, however, because it doesn't have an obvious pocket, or binding site, that a drug could fit into to block its activity, says Frank McCormick, who recently stepped down as director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, to spend half his time directing NCI's RAS projDrug companies had long ago given up on targeting RAS, however, because it doesn't have an obvious pocket, or binding site, that a drug could fit into to block its activity, says Frank McCormick, who recently stepped down as director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, to spend half his time directing NCI's RAS projdrug could fit into to block its activity, says Frank McCormick, who recently stepped down as director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, to spend half his time directing NCI's RAS project.

So executioners in Florida experiment on condemned prisoners with untried cocktails of drugs because pharmaceutical companies deny them their tried...

And no company would embark on such an expensive drug search because it would never recoup its investment with such a rare disease.

Because this idea was so attractive to researchers studying brain diseases, a large number of potential drugs were developed by pharmaceutical companies that block glutamate receptors, including mGluR5.

«IKKs are one of the most heavily sought after drug targets today, because pharmaceutical companies want safe and effective medications to treat the pain of arthritis, now that the safety of COX - 2 inhibitors, like Celebrex and Vioxx, have been called into question,» says Salk researcher Vinay Tergaonkar who was involved in the zebrafish study.

These trials from WAVE are slightly unique, because the company has not conducted studies in HD animal models with their specific drugs.

Researchers said the ability to record those two functions would be useful to pharmaceutical companies because it could alert drug manufacturers to cardiac problems caused by a drug early in the process before reaching the clinical trial stage.

There is a perception amongst companies that doing drug development in neurologic diseases is incredibly risky, partly because animal models often fail to predict outcomes in clinical trials.

Because regulators are on the lookout for sibutramine, some companies are altering the drug's molecules so it's undetectable in tests.

Patented drugs are important to drug company profits because the company that invents them can sell them exclusively for many years, and thus they can charge more for them because there's no competition.